がん治療情報システムの世界市場...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 17
1.4 MARKETS COVERED 18
1.4.1 YEARS CONSIDERED IN THE STUDY 19
1.5 CURRENCY 19
1.6 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY DATA 21
2.1.2.1 Key data from primary sources 22
2.1.2.2 Key industry insights 22
2.1.2.3 Breakdown of primaries 23
2.2 MARKET SIZE ESTIMATION 23
2.2.1.1 Bottom-up approach 23
2.2.1.2 Top-down approach 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 26
2.4.1 ASSUMPTIONS 26
2.4.2 LIMITATIONS 27

3 EXECUTIVE SUMMARY 28
3.1 INTRODUCTION 28
3.2 CURRENT SCENARIO 28
3.3 FUTURE OUTLOOK 29
3.4 CONCLUSION 31

4 PREMIUM INSIGHTS 32
4.1 GROWTH POTENTIAL OF THE ONCOLOGY INFORMATION SYSTEMS MARKET 32
4.2 ONCOLOGY INFORMATION SYSTEMS MARKET, BY SOFTWARE 33
4.3 ONCOLOGY INFORMATION SYSTEMS MARKET, BY SERVICE 34
4.4 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION 35
4.5 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION 36
 
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET SEGMENTATION 38
5.2.1 BY PRODUCTS AND SERVICES 38
5.2.2 BY APPLICATION 39
5.2.3 BY END USER 39
5.3 MARKET DYNAMICS 40
5.3.1 DRIVERS 41
5.3.1.1 Innovation to support new product development 41
5.3.1.2 Rising incidence of cancer 41
5.3.1.3 Increasing recurrence of secondary cancer 42
5.3.1.4 Increasing customer base for OIS software 43
5.3.1.5 Increased investment in healthcare IT 43
5.3.2 RESTRAINTS 45
5.3.2.1 Shortage of healthcare IT professionals 45
5.3.2.2 High maintenance and service expenditure 45
5.3.2.3 Unfavorable healthcare reforms in the U.S. 45
5.3.3 OPPORTUNITIES 46
5.3.3.1 Emerging markets 46
5.3.3.2 Strategic acquisitions 47
5.3.3.3 Multi-year contracts and agreements offer significant long-term business opportunities 47
5.3.4 CHALLENGES 48
5.3.4.1 Privacy and security issues 48
5.3.4.2 Need for training to operate oncology information systems 49

6 INDUSTRY INSIGHTS 50
6.1 INTRODUCTION 50
6.2 INDUSTRY TRENDS 50
6.2.1 CONSOLIDATION AMONG HOSPITALS AND CLINICS 50
6.2.2 STRONG FOCUS ON EDUCATION AND TRAINING 50
6.3 PORTER’S FIVE FORCES ANALYSIS 51
6.3.1 THREAT FROM NEW ENTRANTS 51
6.3.2 THREAT FROM SUBSTITUTES 52
6.3.3 BARGAINING POWER OF BUYERS 52
6.3.4 BARGAINING POWER OF SUPPLIERS 53
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 53

7 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCTS AND SERVICES 54
7.1 INTRODUCTION 55
7.2 ONCOLOGY INFORMATION SYSTEMS MARKET, BY SOFTWARE 58
7.2.1 INTRODUCTION 58
7.2.2 PATIENT INFORMATION SYSTEMS 61
7.2.3 TREATMENT PLANNING SYSTEMS 64
7.3 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PROFESSIONAL SERVICES 66
7.3.1 INTRODUCTION 66
7.3.2 IMPLEMENTATION SERVICES 69
7.3.3 POST-SALE AND MAINTENANCE SERVICES 71
7.3.4 CONSULTING/OPTIMIZATION SERVICES 73

8 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION 75
8.1 INTRODUCTION 76
8.2 MEDICAL ONCOLOGY 79
8.3 RADIATION ONCOLOGY 80
8.4 SURGICAL ONCOLOGY 81

9 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER 82
9.1 INTRODUCTION 83
9.2 HOSPITALS & PHYSICIANS’ OFFICES 85
9.3 GOVERNMENT INSTITUTES 87
9.4 RESEARCH CENTERS 87

10 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION 88
10.1 INTRODUCTION 89
10.2 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION 89
10.2.1 NORTH AMERICA 91
10.2.1.1 U.S. 93
10.2.1.2 Canada 95
10.2.2 EUROPE 97
10.2.2.1 Germany 99
10.2.2.2 U.K. 101
10.2.2.3 France 102
10.2.2.4 Rest of Europe 103
10.2.3 ASIA-PACIFIC 105
10.2.3.1 Japan 108
10.2.3.2 China 109
10.2.3.3 India 111
10.2.3.4 Rest of Asia-Pacific (RoAPAC) 112
10.2.4 REST OF THE WORLD (ROW) 113

11 COMPETITIVE LANDSCAPE 118
11.1 OVERVIEW 118
11.2 MARKET SHARE ANALYSIS 118
11.3 COMPETITIVE SITUATION AND TRENDS 119
11.3.1 PRODUCT APPROVALS, LAUNCHES, AND PRODUCT ENHANCEMENT 121
11.3.2 MERGERS AND ACQUISITIONS 122
11.3.3 EXPANSION 123
11.3.4 OTHER DEVELOPMENTS 124

12 COMPANY PROFILES 126
(Overview, Financials, Products & Services, Strategy, & Developments)*
12.1 ACCURAY INCORPORATED 126
12.2 ADVANCED DATA SYSTEMS CORPORATION 129
12.3 CERNER CORPORATION 131
12.4 ELEKTA AB 134
12.5 EPIC SYSTEMS CORPORATION 139
12.6 FLATIRON HEALTH, INC. 141
12.7 GENERAL ELECTRIC COMPANY 144
12.8 PHILIPS HEALTHCARE (A DIVISION OF KONINKLIJKE PHILIPS N.V.) 146
12.9 MCKESSON CORPORATION 149
12.10 VARIAN MEDICAL SYSTEMS, INC. 152
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

13 APPENDIX 156
13.1 INSIGHTS OF INDUSTRY EXPERTS 156
13.2 DISCUSSION GUIDE 157
13.3 DEVELOPMENTS 162
13.3.1 ACCURAY INCORPORATED 162
13.3.2 ADVANCED DATA SYSTEMS CORPORATION 162
13.3.3 CERNER CORPORATION 163
13.3.4 ELEKTA AB 163
13.3.5 FLATIRON HEALTH, INC. 165
13.3.6 VARIAN MEDICAL SYSTEMS, INC. 167
13.4 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 170
13.5 AVAILABLE CUSTOMIZATIONS 171
13.6 RELATED REPORTS 172